BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14991949)

  • 1. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.
    Mochizuki K; Kagawa T; Takashimizu S; Kawazoe K; Kojima S; Nagata N; Nakano A; Nishizaki Y; Shiraishi K; Itakura M; Watanabe N; Mine T; Matsuzaki S
    World J Gastroenterol; 2004 Mar; 10(5):733-6. PubMed ID: 14991949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
    Kakizaki S; Takagi H; Yamada T; Ichikawa T; Abe T; Sohara N; Kosone T; Kaneko M; Takezawa J; Takayama H; Nagamine T; Mori M
    J Viral Hepat; 1999 Jul; 6(4):315-9. PubMed ID: 10607246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV RNA in serum and peripheral blood mononuclear cells after successful interferon therapy.
    Mohamad HI; El-Bab HK; Kamal AM
    Hepatogastroenterology; 2011; 58(107-108):932-6. PubMed ID: 21830419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
    Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
    Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of persistence of IFN-alpha treatment response in chronic hepatitis C patients according with HCV-RNA presence in PBMC].
    Piekarska A; Sidorkiewicz M; Lewandowska U; Kuydowicz J
    Pol Arch Med Wewn; 2001 Oct; 106(4):939-44. PubMed ID: 11993413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Miyazaki K; Kuwata Y; Yamazaki K; Sato T; Ohmura T; Matsushima T
    J Gastroenterol Hepatol; 2003 Apr; 18(4):404-10. PubMed ID: 12653888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
    Majda-Stanisławska E; Bednarek M; Jóźwiak B; Sidorkiewicz M; Piekarska A; Kuydowicz J
    Acta Gastroenterol Belg; 2006; 69(2):187-90. PubMed ID: 16929613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment.
    Taliani G; Badolato C; Lecce R; Poliandri G; Bozza A; Duca F; Pasquazzi C; Clementi C; Furlan C; De Bac C
    J Med Virol; 1995 Sep; 47(1):16-22. PubMed ID: 8551253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HCV RNA in the peripheral blood mononuclear cells of serum HCV RNA-negative Egyptian patients under interferon treatment.
    Zayed RA; Rushdy E; Saleh DA
    Am J Med Sci; 2010 Dec; 340(6):435-8. PubMed ID: 20811275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta.
    Shiratori Y; Perelson AS; Weinberger L; Imazeki F; Yokosuka O; Nakata R; Ihori M; Hirota K; Ono N; Kuroda H; Motojima T; Nishigaki M; Omata M
    J Hepatol; 2000 Aug; 33(2):313-22. PubMed ID: 10952250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?
    Meier V; Mihm S; Braun Wietzke P; Ramadori G
    World J Gastroenterol; 2001 Apr; 7(2):228-34. PubMed ID: 11819765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.
    Arase Y; Suzuki F; Sezaki H; Kawamura Y; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Yatsuji H; Kobayashi M; Saitoh S; Ikeda K; Kumada H
    Intern Med; 2008; 47(12):1085-90. PubMed ID: 18552464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late spontaneous elimination of HCV-RNA from mononuclear cells derived from peripheral blood in patients with chronic hepatitis C].
    Majda-Stanisławska E; Sidorkiewicz M; Jóźwiak B; Pietrzak A; Brzezińska-Błaszczyk E
    Przegl Epidemiol; 2006; 60(1):79-85. PubMed ID: 16758743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA.
    Muratori L; Giostra F; Cataleta M; Francesconi R; Ballardini G; Cassani F; Lenzi M; Bianchi FB
    Liver; 1994 Jun; 14(3):124-8. PubMed ID: 8078391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in hepatitis C virus (HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients.
    Fallows G; Kaita K; Minuk G; Penner F; Smart G; Dawood M; Rosser B
    Can J Gastroenterol; 2000; 14 Suppl B():30B-35B. PubMed ID: 10938502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.